These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 1992623

  • 21. Observations on the effect of a somatostatin analog in the Zollinger-Ellison syndrome: implications for the treatment of apudomas.
    Ellison EC, O'Dorisio TM, Sparks J, Mekhjian HS, Fromkes JJ, Woltering EA, Carey LC.
    Surgery; 1986 Aug; 100(2):437-44. PubMed ID: 2426819
    [Abstract] [Full Text] [Related]

  • 22. Serum gastrin response to secretin after vagotomy.
    Feldman M, Walsh JH, Richardson CT.
    Dig Dis Sci; 1980 Dec; 25(12):921-3. PubMed ID: 7449589
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [A study of secretin dosage of secretin provocation test in the Zollinger-Ellison syndrome].
    Matsui T, Iida M, Nanbu T, Kohrogi N.
    Nihon Shokakibyo Gakkai Zasshi; 1985 Feb; 82(2):288-95. PubMed ID: 3999447
    [No Abstract] [Full Text] [Related]

  • 29. Zollinger-Ellison syndrome associated with persistently normal fasting serum gastrin concentrations.
    Wolfe MM, Jain DK, Edgerton JR.
    Ann Intern Med; 1985 Aug; 103(2):215-7. PubMed ID: 4014903
    [Abstract] [Full Text] [Related]

  • 30. Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach.
    Fishbeyn VA, Norton JA, Benya RV, Pisegna JR, Venzon DJ, Metz DC, Jensen RT.
    Ann Intern Med; 1993 Aug 01; 119(3):199-206. PubMed ID: 8323088
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pseudo-Zollinger-Ellison syndrome: hypergastrinemia, hyperchlorhydria without tumor.
    Friesen SR, Tomita T.
    Ann Surg; 1981 Oct 01; 194(4):481-93. PubMed ID: 7283508
    [Abstract] [Full Text] [Related]

  • 35. Gastrin and secretin radioimmunoassay in diagnosis and therapy of acid-peptic disease.
    Straus E, Greenstein RJ, Yalow RS.
    Mt Sinai J Med; 1979 Oct 01; 46(2):87-90. PubMed ID: 312455
    [No Abstract] [Full Text] [Related]

  • 36. Diagnostic efficacy of the secretin stimulation test for the Zollinger-Ellison syndrome: an intra-individual comparison using different dosages in patients and controls.
    Kuiper P, Biemond I, Masclee AA, Jansen JB, Verspaget HW, Lamers CB.
    Pancreatology; 2010 Oct 01; 10(1):14-8. PubMed ID: 20299818
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Gastrinoma: diagnosis and management of Zollinger-Ellison syndrome].
    Sugihara K.
    Nihon Geka Gakkai Zasshi; 1984 Sep 01; 85(9):1044-8. PubMed ID: 6150432
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Clinical significance of glucagon provocation test in the diagnosis of hypergastrinemia.
    Nakanome C, Ishimori A, Goto Y, Yamazaki T, Kameyama J, Sasaki I, Inui M, Furukawa Y, Komatsu K.
    Gastroenterol Jpn; 1981 Sep 01; 16(3):213-22. PubMed ID: 6114893
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.